(UroToday.com) The 2025 SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Garmezy discussing a phase 1 trial of mevrometostat (PF-06821497), a potent and ...

A novel inhibitor-loaded bilayer hybrid system based on the LDH inner layer and MOF outer layer is designed on an aluminum alloy 2A12 surface to improve corrosion performance. The hybrid film system ...

PO.1.1 Afimetoran, a potent and selective inhibitor of human toll-like receptor 7 (TLR7) and tlr8, provides robust efficacy in a murine lupus model of advanced disease ...

The combination of a calcineurin inhibitor and an antimetabolite remains standard care for graft-versus-host disease (GVHD) prophylaxis in these patients.

"With our potentially best-in-class BCL2 inhibitor, sonrotoclax, and first-in-class BTK degrader, BGB-16673, we are advancing innovative therapies aimed at addressing resistance mechanisms and ...

Cortec claims to have developed the 'world's first' certified industrially compostable vapour corrosion inhibitor paper to package protective metals, highlighting its 92% USDA-certified biobased ...

Panelists discuss how risk stratification, symptom burden, and splenomegaly guide treatment decisions for a 68-year-old woman with intermediate-risk myelofibrosis who isn’t interested in transplant.

Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filings Phase 1 ...

GPs can start treatment with certain heart failure drugs that previously had to be initiated by a specialist, NICE has said.

1-D and 2-D Photonic Crystals as Optical Methods for Amplifying Biomolecular Recognition Label-free sensing strategies are an intensely studied and increasingly used alternative to signal ...

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns.

DeepCure, an immunology therapeutics company leveraging artificial intelligence (AI) to rapidly advance novel small molecule drugs, today announced the nomination of DC-15442 as its second ...